These include several prior validated targets affected in DCM patients with the RBM20 S635A mutation, such as TTN, CAMK2D, OBSCN, RYR2, IMMT, and TNNT2 (Fig. 4b–d, and Supplementary Fig. 5b)16. Here, TTN is linked to familial dilated cardiomyopathy.